New Treatment for Bladder Cancer Offers This Biotech a Second Chance

UroGen Pharma said it expects more data on the drug’s durability of response next year, when it hopes to submit it for FDA approval.#urogenpharma #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news